Knight Therapeutics Inc. (FRA:04K)
Germany · Delayed Price · Currency is EUR 3.580
+0.040 (1.13%)
Last updated: Jan 29, 2026, 8:53 AM CET
Knight Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -3.49 | 4.33 | -16.84 | -29.89 | 15.68 | 42.07 |
Depreciation & Amortization | 54.53 | 52.18 | 49.52 | 61.97 | 47.63 | 31.93 |
Other Amortization | 0.93 | 0.93 | 0.88 | 0.65 | 0.29 | 0.14 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | -2.99 |
Asset Writedown & Restructuring Costs | - | - | 9.26 | 23.98 | 0.5 | 0.66 |
Loss (Gain) From Sale of Investments | 3.08 | 11.91 | 9.52 | 21.24 | -18.42 | -48.71 |
Stock-Based Compensation | 4.69 | 1.86 | 2.33 | 1.89 | 3.05 | -2.22 |
Other Operating Activities | -2.04 | -14.83 | 8.58 | -28.81 | -4.2 | -10.2 |
Change in Accounts Receivable | -20.99 | -8.33 | 5.25 | -31.12 | 6.25 | 20.11 |
Change in Inventory | -19.67 | -5.91 | 0.7 | -11.43 | -17.19 | 9.71 |
Change in Accounts Payable | 23.26 | 0.63 | -21.63 | 35.12 | 11.46 | -46.86 |
Change in Income Taxes | -1.33 | -2.6 | -0.84 | 2.67 | -6.87 | -1.96 |
Change in Other Net Operating Assets | -3.41 | -3.42 | -11.49 | -0.71 | 6.98 | -4.58 |
Operating Cash Flow | 35.55 | 36.28 | 35.94 | 45 | 44.62 | -12.21 |
Operating Cash Flow Growth | -32.60% | 0.95% | -20.14% | 0.86% | - | - |
Capital Expenditures | -1.96 | -2.47 | -0.95 | -2.89 | -3.83 | -5.38 |
Sale of Property, Plant & Equipment | 0.13 | 0.1 | 1.92 | - | - | - |
Cash Acquisitions | -110.08 | - | - | - | - | -170.86 |
Sale (Purchase) of Intangibles | -30.75 | -29 | -9.01 | -22.93 | -220.35 | -15.29 |
Investment in Securities | 55.73 | 33.55 | 11.3 | -38.91 | 85.29 | 263.31 |
Other Investing Activities | 16.82 | 14.69 | 2.43 | 3.99 | 30.93 | 29.13 |
Investing Cash Flow | -52.53 | 16.96 | 29.34 | -63.08 | -105.28 | 101.35 |
Long-Term Debt Issued | - | 3.47 | 4.8 | 51.78 | 9.42 | 24.58 |
Total Debt Issued | 111.75 | 3.47 | 4.8 | 51.78 | 9.42 | 24.58 |
Long-Term Debt Repaid | - | -21.52 | -22.82 | -20.29 | -23.62 | -17.85 |
Total Debt Repaid | -71.56 | -21.52 | -22.82 | -20.29 | -23.62 | -17.85 |
Net Debt Issued (Repaid) | 40.18 | -18.05 | -18.02 | 31.49 | -14.19 | 6.73 |
Issuance of Common Stock | 0.74 | 1 | 0.38 | 0.34 | 0.3 | 0.83 |
Repurchase of Common Stock | -8.5 | -8.87 | -53.48 | -30.07 | -64.42 | -36.79 |
Other Financing Activities | -7.57 | -7.63 | -9.88 | -4.52 | - | - |
Financing Cash Flow | 24.85 | -33.54 | -81 | -2.76 | -78.31 | -29.23 |
Foreign Exchange Rate Adjustments | 0.24 | 1.64 | 2.8 | 6.55 | -4.66 | -4.59 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 |
Net Cash Flow | 8.12 | 21.35 | -12.92 | -14.28 | -143.63 | 55.32 |
Free Cash Flow | 33.59 | 33.81 | 34.99 | 42.12 | 40.79 | -17.58 |
Free Cash Flow Growth | -33.36% | -3.37% | -16.92% | 3.26% | - | - |
Free Cash Flow Margin | 8.12% | 9.11% | 10.66% | 14.35% | 16.75% | -8.81% |
Free Cash Flow Per Share | 0.34 | 0.33 | 0.33 | 0.37 | 0.33 | -0.13 |
Cash Interest Paid | 7.57 | 7.63 | 9.88 | 4.52 | 2.64 | 1.97 |
Cash Income Tax Paid | 3.3 | 5.48 | 5.42 | 5.67 | 8.57 | 6.64 |
Levered Free Cash Flow | -7.98 | -9.7 | 27.09 | 2.88 | -165.58 | -182.03 |
Unlevered Free Cash Flow | -2.39 | -3.94 | 34.89 | 7 | -163.32 | -179.91 |
Change in Working Capital | -22.13 | -19.62 | -28.01 | -5.47 | 0.63 | -23.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.